Quantcast

Latest Cancer Research Stories

2014-03-31 08:30:41

Morgan Stanley's Head of Global Biotech Investment Banking Joins Leading Cancer Immunotherapy Startup SEATTLE, March 31, 2014 /PRNewswire/ -- Juno Therapeutics, a biotechnology company focused on bringing forward novel immunotherapies for cancer, announced today that Steve Harr, M.D., will join the company as its Chief Financial Officer and Head of Corporate Development. http://photos.prnewswire.com/prnvar/20140113/DC45426LOGO Harr currently serves as Managing Director and Head of...

2014-03-27 12:30:31

Portion of Proceeds from Connexion 2014 Earmarked to Provide Financial and Emotional Relief for Families and Patients Battling Cancer FOXBORO, Mass., March 27, 2014 /PRNewswire/ -- Axeda Corporation, the leading cloud-based service and software for connecting, building and managing Internet of Things (IoT) solutions, today announced its support of the Joe Andruzzi Foundation (JAF), a Massachusetts-based nonprofit 5019(c)(3) organization dedicated to alleviating cancer's financial and...

2014-03-26 16:11:46

A breast cancer therapy that blocks estrogen synthesis to activate cancer-killing genes sometimes loses its effectiveness because the cancer takes over epigenetic mechanisms, including permanent DNA modifications in the patient's tumor, once again allowing tumor growth, according to an international team headed by the University of Pittsburgh Cancer Institute (UPCI). The finding warrants research into adding drugs that could prevent the cancer from hijacking patients' repressive gene...

2014-03-26 12:28:50

Enabled Reduced Analysis Time Per Case, Improved Ability to Track & Query Identified Variants BOSTON and LEUVEN, Belgium, March 26, 2014 /PRNewswire/ -- Cartagenia, the world leader in software-based workflow support for genetic variant assessment, lab reporting, and integration of diagnostic knowledge-bases, today announced that the Human Genetics Laboratory, part of the Munroe-Meyer Institute for Genetics and Rehabilitation (MMI) at the University of Nebraska Medical Center (UNMC),...

2014-03-25 23:32:12

The globally standardized certification methodology is now accepted across healthcare organizations, clinical trial sponsors, CROs and regulatory agencies. Austin, TX (PRWEB) March 25, 2014 More than 500,000 healthcare and clinical research professionals in 164 countries representing every continent have been trained and certified on the NIH Stroke Scale (NIHSS) and can now share their standardized certifications electronically across employees, sponsors and clinical trials via HCP’s...

2014-03-24 12:29:44

WASHINGTON, March 24, 2014 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders, today announced the names of 15 research investigators who will receive critical interim support from the Society for hematology research proposals that, despite earning high scores, could not be funded by the National Institutes of Health (NIH) amid severe funding reductions. The support...

2014-03-20 23:27:34

Inaugural Gateway to Wellness event at Catalyst Ranch to feature food, fun and new ideas for leading healthy lifestyles. Event to benefit the nonprofit Gateway for Cancer ResearchSM. SCHAUMBURG, Ill. (PRWEB) March 20, 2014 While cancer can be devastating for those it affects, working to find cures can be a source of joy and reward. It’s with this sense of optimism that Chicago-area young professionals will gather the evening of Saturday, April 5, at Gateway to Wellness, a...

2014-03-20 23:22:02

Entinostat is being investigated in patients with advanced hormone receptor-positive breast cancer by the ECOG-ACRIN Cancer Research Group in its latest trial, E2112. Philadelphia, PA, and Waltham, MA (PRWEB) March 20, 2014 The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Syndax Pharmaceuticals, Inc., announced today that patient recruitment has begun for E2112, a randomized phase III clinical trial of Syndax’s entinostat in treatment of patients with advanced breast cancer. The...

2014-03-20 23:02:41

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. Sacramento, CA (PRWEB) March 20, 2014 Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The...

2014-03-20 08:29:42

VANCOUVER, British Columbia and MENLO PARK, Calif., March 20, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") provided an update as of the quarter ended December 31, 2013 and a summary of progress toward the Company's goals for the year. DelMar also announced an investor conference call to take place today at 1 pm EDT. Details and log-in information will be posted on the website at www.delmarpharma.com in advance of the call....


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'karpos', fruit.
Related